Global Director Ocular Health New Products
CurrentLeading global Ocular Health innovation strategy and plans founded on targeted consumer segments' and Eye Care practitioners' need states and unmet needs to define and progress priority innovation territories and portfolio pipeline projectsFocused on growing portfolio via disruptive innovations that deliver enhanced value via performance and experience to advance brand goals (Systane, Pataday, and new to world brands), fuel category development, and enrich consumers' everyday lives.Leading Ocular Health consumer goods OTC/Rx innovations in partnership with R&D, Market Research, Clinical, Regulatory, Health Economics, BD&L, Business Regions, and other key functional areas to advance projects through state gate process: inclusive of product strategy, concept development to validation, target product profile, prioritized claims, packaging design, and complete business caseLeading development to commercialization planning for new OTC lifestyle eye care entry, inclusive of portfolio strategy, branding, design, and communications strategy with supporting 360 media plan